Iscador Qu for chronic hepatitis C: an exploratory study
Related Experiment Video
Updated: Oct 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
K J Tusenius1, J M Spoek, C W Kramers
1Berg en Bosch Medical Centre, Bilthoven, the Netherlands. tusenius@worldonline.nl
Abstract:
Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...